Tianjin Jinhong Shengli Pharmaceutical

Tianjin Jinhong Shengli Pharmaceutical is a comprehensive pharmaceutical enterprise based in Tianjin, China, focused on the research, development, and manufacturing of chemical APIs and finished drug products. The company maintains a diverse portfolio that addresses critical therapeutic areas such as cardiovascular health, gastroenterology, and infectious diseases. Operating under strict GMP standards, the firm produces a wide range of oral solid dosages and active ingredients, including well-known treatments like Famotidine and Amlodipine. In addition to its own product line, the company provides contract manufacturing and development services to global and domestic partners. Tianjin Jinhong Shengli Pharmaceutical is recognized for its integrated supply chain, from raw material synthesis to final packaging. The company was previously listed on China's National Equities Exchange and Quotations (NEEQ) to support its growth and modernization efforts.